$JBL

Jabil Rises 36.2% Year to Date: Should You Buy the Stock?

Jabil Inc. (JBL) has risen 36.2% year-to-date, outperforming its industry and the S&P 500. The company expects AI-related revenues to reach $13.6B in fiscal 2026, up from $9B in 2025, and is expanding manufacturing capacity to meet demand. JBL also sees growth in healthcare, renewable energy, and digital commerce sectors, but faces supply chain and competition challenges.

Original reporting
Published Sep 7, 2026, 3:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 7, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jabil Rises 36.2% Year to Date: Should You Buy the Stock? — source image
Decision brief

The 30-second read

$JBLBullishMed
01

Why it matters

The new AI revenue guidance suggests a significant growth tailwind, but execution risk remains.

02

Market read

Jabil's guidance upgrade may attract investors seeking exposure to AI hardware manufacturing.

03

What to watch

Potential supply‑chain constraints and higher capex requirements could pressure margins.

Relevance 8/10Novelty 8/10Timing: today

Background

Jabil is a leading electronic manufacturing services provider that has been emphasizing AI infrastructure work.

Company-level read

Ticker impact

$JBLBullishHigh confidence
Context

Jabil raised AI-related revenue guidance to $13.6B for fiscal 2026, up from $9B previously.

Expected impact

Potential upside of 5‑10% over the next few weeks if market digests the guidance.

Evidence & confidence

Guidance increase is material, backed by expansion plans in AI manufacturing capacity.

Market effects

Highlights growing AI infrastructure demand, benefiting the broader EMS and semiconductor supply chain.

U.S. manufacturing and tech sectors may see modest gains.

Signals continued global AI spending, supporting related hardware exporters.

Counterpoint

If AI demand stalls, the guidance lift could be premature, leading to a correction.

Key entities

  • Jabil Inc.

    Electronic manufacturing services firm (ticker JBL).

Related articles

$JBLHighAI 8/10

FDA Contamination Warning Could Be A Game Changer For Jabil’s (JBL) Pharma Ambitions

The FDA issued a warning to Jabil's Pharmaceutics International facility, citing significant violations of sterile drug manufacturing practices, including fungal contamination and weak quality oversight. This raises concerns about Jabil's ability to manufacture sterile products and could impact its pharmaceutical expansion plans. Jabil's 2026 revenue guidance of $35 billion includes contributions from healthcare and pharma, which may now be questioned by investors.

$JBLHighAI 8/10

Jabil Stock: Is Wall Street Bullish or Bearish?

Jabil Inc. (JBL), a $33.8B electronic manufacturing services provider, reported Q3 2026 adjusted EPS of $3.16 and revenue of $8.75B, exceeding expectations. The company raised its fiscal 2026 guidance, citing strong AI data-center demand and new partnerships. Shares have surged 58.6% over 52 weeks, outperforming the S&P 500. Analysts rate it a 'Strong Buy' with a mean price target of $451.18.

$JBLMed

Jabil upgraded by UBS as AI demand, healthcare growth support outlook

UBS upgraded Jabil Inc (JBL) to Buy and raised estimates, saying a multiyear growth cycle is supported by AI investment, healthcare demand, and expanding automation and robotics. UBS set a $430 price target and lowered its valuation multiple to about 22x. It forecasts AI revenue growth to about $20.3B in FY2027, raised EPS to $16.78 (FY2027) and $20.24 (FY2028).

$JBLMed

Stocks making the biggest moves midday: Jabil, AppLovin, Apollo, SpaceX, Upwork & more

Midday movers included Jabil, up 5% after a UBS upgrade to Buy, and AppLovin, down 5% after Bank of America downgraded to neutral and cut its price target to $400. Aramark rose 9% after Q3 beat and raised forecast. Under Armour fell 8% on a Barclays downgrade. Upwork dropped 13% on weaker guidance. Fermi jumped 22% after a first binding lease with TensorWave for 222 MW and about $6.5B contracted revenue.